Comments
Commented by Fabian Lorenz on September 29th, 2025 | 07:00 CEST
Takeover in the Ozempic market! BioNxt Solutions next? Novo Nordisk, Eli Lilly, and Pfizer are fighting!
The battle against obesity is considered one of the biggest growth markets in the global pharmaceutical sector. According to estimates, the market for obesity therapies could reach a volume of up to USD 150 billion by 2030. So far, Novo Nordisk and Eli Lilly have dominated the market. But almost every major corporation and innovative challenger wants a piece of the pie. The latest example: Pfizer is planning a billion-dollar takeover of US-based Metsera, a company competing with novel drugs against obesity. BioNxt Solutions is also a hot takeover candidate. The Company aims to revolutionize the market and attract new customers with an oral dosage form, and the first prototypes have already been developed. That makes it an attractive prospect for virtually every pharmaceutical company.
Read
Commented by Armin Schulz on September 26th, 2025 | 08:25 CEST
Palantir, Aspermont, ProSiebenSat.1 Media – Data as a gold mine! Where can you profit?
In a world where data is the new gold, the ability to turn this data into competitive advantages and profit determines success or failure. While tech giants set the rules, established players must radically rethink their approach. Three companies exemplify how differently this transformation can be mastered. The sometimes controversial data analysis company Palantir, the niche publisher Aspermont, which monetizes specialist information, and the media giant ProSiebenSat.1 Media, which aims to link conventional television with the online world. Their strategies reveal where the greatest opportunities lie.
Read
Commented by André Will-Laudien on September 26th, 2025 | 08:20 CEST
Bitcoin at USD 250,000? Quantum computers conquer crypto – Favor D-Wave, Finexity and Alibaba now!
The financial markets are undergoing a profound transformation, with speed and computing power becoming decisive competitive advantages. High-performance computers have already revolutionized stock market trading by implementing complex strategies in milliseconds. At the same time, blockchain technology and crypto platforms are creating a new market that is benefiting massively from these technological developments. Whether in high-frequency trading, hedging digital assets, or building tokenized securities markets, the interplay of computing power and decentralized networks is opening up access to a whole new dimension of global financial flows. Which stocks offer opportunities?
Read
Commented by Carsten Mainitz on September 26th, 2025 | 07:35 CEST
Gerresheimer, dynaCERT, Volkswagen – Exciting developments!
News drives prices. However, the pendulum can swing in both directions. For informed investors, the correct interpretation of events is crucial. Often, this then leads to lucrative entry and exit signals. Gerresheimer was the latest to be hit, but which stock could be next? However, there are also stocks that are due for a realignment, offering opportunities for rising prices.
Read
Commented by Nico Popp on September 26th, 2025 | 07:30 CEST
AI is conquering increasingly more areas: SAP and Amazon are targeting small and mid-sized businesses, while NetraMark is winning over the biotech industry
Will AI become our new god? This question is currently being explored in depth by the German philosopher Markus Gabriel in a well-known German podcast. And although the question may cause unease for many, Gabriel's conclusions are ultimately anything but pessimistic. SAP and Amazon are also looking to the future with optimism: Together with OpenAI, they are now building an AI infrastructure in Germany. The goal: to enable public authorities and companies to use the latest AI tools in a legally compliant manner, without European data leaving the continent. The initiative demonstrates that AI will conquer many more areas in the coming years. One of these areas is medical research. The innovative company NetraMark is using its AI solution to deliver faster results and lower costs for future-focused projects, such as the fight against cancer.
Read
Commented by André Will-Laudien on September 26th, 2025 | 07:25 CEST
Shooting down Russian drones and fighter jets? NATO keeps its focus on Rheinmetall, Almonty and Hensoldt!
On the financial markets, Russian provocations involving jet and drone overflights are primarily perceived as a security risk. Such actions increase political instability and often trigger a flight to safe havens such as gold, government bonds, or the US dollar. At the same time, defense stocks and companies in the security sector tend to benefit, as investors anticipate rising defense spending in Europe and within NATO. For the broader equity market, the increased risk often translates into higher volatility and temporary price setbacks. In the long term, such threat scenarios are factored into risk premiums and valuation models, leading to more selective capital allocation in security-related sectors. Here are a few ideas.
Read
Commented by Nico Popp on September 26th, 2025 | 07:20 CEST
One-stop shop – Battery metals from a single source: Umicore, BASF, Power Metallic Mines
Anyone who is often in a rush knows the challenge after work: just a quick trip to the store. In such cases, we usually head to our trusted supermarket, where we can find all the products we need in one place. The same principle applies in mining. Complex products, such as modern high-performance batteries for electric vehicles, require a wide range of metals. Polymetallic deposits are therefore in particularly high demand – they are like the familiar neighborhood supermarket for industrial customers. We explain why Power Metallic Mines has the potential to become a one-stop shop for potential major customers such as Umicore and BASF.
Read
Commented by André Will-Laudien on September 26th, 2025 | 07:15 CEST
BioNxt Solutions – Biotech specialist with significant leverage in mega markets
Modern medicine faces an enormous challenge: More and more people are suffering from so-called diseases of affluence, such as obesity, diabetes, multiple sclerosis, and MASH, the dreaded fatty liver disease. At the same time, there is a growing need for innovative therapies and new dosage forms that make treatments more effective, simpler, and more patient-friendly. This is precisely where BioNxt Solutions comes in, a young biotech company that is addressing several billion-dollar markets with its patented thin-film technology. By enabling the oral administration of important active ingredients such as semaglutide and cladribine, BioNxt is not only opening up new therapeutic avenues but also significantly enhancing the effectiveness of existing drugs. At a time when pharmaceutical giants are investing billions in new solutions, BioNxt could become one of the most exciting future players in the industry.
Read
Commented by Armin Schulz on September 26th, 2025 | 07:10 CEST
Is the turbo kicking in? A look at the strategies of Plug Power, Pure Hydrogen and Ballard Power
The race for the future of industrial energy is entering its decisive phase. While global energy demand continues to grow unabated, high CO₂ prices and strict climate regulations are driving explosive demand for clean solutions. Green hydrogen, in particular, promises to revolutionize energy-intensive sectors such as steel and logistics, opening up a market worth billions. Pioneers with concrete technologies and projects stand to benefit the most from this boom. This dynamic makes companies like Plug Power, Pure Hydrogen, and Ballard Power key players who are now in the spotlight.
Read
Commented by Fabian Lorenz on September 26th, 2025 | 07:05 CEST
Will silver rise to USD 130? First Majestic Silver, Pan American Silver, Silver North shares!
Silver will shine like gold in 2025. After rallying to over USD 40 per ounce, one super bull even believes it could reach USD 130. He points to supply shortages, strong industrial demand, and its undervaluation relative to gold. At the company level, Silver North Resources is generating news flow with exploration programs in the Yukon and initial indications of new high-grade mineralization. Will the stock soon take off? Pan American Silver is strengthening itself through the acquisition of MAG Silver and reporting record results with 5.1 million ounces of silver. In addition, the dividend has been increased. Analysts see buying opportunities. RBC recently raised its price target for the base investment in the silver sector.
Read